Butyrate Enhances Anti-PD-1 Antitumor Efficacy in Lung Cancer via Modulating STAT1/IDO1-Mediated Tryptophan-Kynurenine Pathway

Chuanchuan Li, Xixi Li, Bo Ma, Feng Yuan, Shouzhong Wang, Weixian Liu

PDF(18999 KB)
For Authors|For Editors|For Reviewers
PDF(18999 KB)
Discovery Medicine ›› 2026, Vol. 38 ›› Issue (204) : 171-187. DOI: 10.24976/Discov.Med.202638204.14
Article

Butyrate Enhances Anti-PD-1 Antitumor Efficacy in Lung Cancer via Modulating STAT1/IDO1-Mediated Tryptophan-Kynurenine Pathway

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 38(204): 171-187 https://doi.org/10.24976/Discov.Med.202638204.14

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(18999 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2026.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉